Anticancer molecular mechanisms of oleocanthal

Area of Science:

• * Molecular Biology
• * Oncology
• * Nutraceuticals

Background:

• * Cancer remains a leading global cause of death, with existing therapies causing significant side effects.
• * There is a critical need for novel anticancer agents with improved safety profiles.
• * Oleocanthal (OLC), a natural phenolic compound in extra virgin olive oil, has demonstrated antitumor potential.

Purpose of the Study:

• * To review and summarize current research on the anticancer activity of oleocanthal (OLC).
• * To elucidate the molecular mechanisms and intracellular targets through which OLC exerts its antitumor effects.
• * To highlight OLC's modulation of key signaling pathways in various cancer cell types.

Main Methods:

• * Comprehensive literature review of studies investigating OLC's anticancer properties.
• * Analysis of research focusing on molecular signaling pathways affected by OLC.
• * Examination of data on OLC's synergistic effects with conventional chemotherapy agents.

Main Results:

• * OLC modulates crucial cancer-related signaling pathways, including apoptosis, HGF/c-Met, and STAT3.
• * Oleocanthal exhibits synergistic effects when combined with existing anticancer drugs in vitro.
• * The review consolidates information on OLC's bioavailability and its presence in olive oil.

Conclusions:

• * Oleocanthal is a promising natural compound with significant anticancer potential.
• * Understanding OLC's molecular mechanisms provides a foundation for developing new cancer therapies.
• * Further research into OLC could lead to more effective and less toxic cancer treatments.